PATENT CLAIM ANALYSIS

Application Number: 16067676
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "520000"]

Abstract:
Provided are compounds of formulae provided herein. The compounds may include pathway-preferential estrogens (PaPEs) derivatives with tissue-selective activities. Also provided are pharmaceutical compositions comprising the compounds, as well as methods of treating a disease or condition including administering the compounds. The disease or condition may include postmenopausal symptoms, cardiovascular disease, stroke, vascular disease, bone disease, metabolic disease, arthritis, osteoporosis, obesity, vasomotor/hot flush, cognitive decline, cancer including breast cancer.

Claim (Index 51):
A compound according to any one of  claims 39 - 50 , wherein R 5  is H.

Metadata:
- Claim Count in Document: 4.0
- Percentile: 95.0
- Lexical Diversity: 1.65385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15440396', '14886332', '13594223', '14790313', '13770706']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7348268835409018
- 35 USC 102 Novelty (BERT): 0.5273163810873962
- Combined Prediction Score: 0.7140758332955512
- Mean Citation Score: 294.405804
- Max Citation Score: 299.8177
- Similarity Product: 194.61165288645032

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test